{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T05:53:48Z","timestamp":1768802028208,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.vaccine.2011.08.123","type":"journal-article","created":{"date-parts":[[2011,9,11]],"date-time":"2011-09-11T20:30:50Z","timestamp":1315773050000},"page":"2387-2395","source":"Crossref","is-referenced-by-count":14,"title":["Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis"],"prefix":"10.1016","volume":"30","author":[{"given":"J.","family":"Marzoa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Costoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Di\u00e9guez-Casal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Freixeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Brookes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.R.","family":"Gorringe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Ferreir\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Criado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.08.123_bib0005","first-page":"355","article-title":"Antigenic similarities between brain components and bacteria causing meningitidis: implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0010","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/S0264-410X(02)00151-2","article-title":"Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants","volume":"20","author":"Longworth","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0015","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1016\/j.vaccine.2008.09.041","article-title":"Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures","volume":"26","author":"J\u00e4kel","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2011.08.123_bib0020","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2009.04.071","article-title":"Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis","volume":"27","author":"Holst","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0025","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2005.01.063","article-title":"MENZB\u2122: a safe and highly immunogenic taylor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain","volume":"23","author":"Oster","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0030","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1590\/S0074-02761999000400002","article-title":"The epidemiological impact of antimeningococcal B vaccination in Cuba","volume":"94","author":"Rodr\u00edguez","year":"1999","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0035","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.resmic.2005.06.011","article-title":"Cross-linking analysis of antigenic outer membrane protein complexes of Neisseria meningitidis","volume":"157","author":"S\u00e1nchez","year":"2006","journal-title":"Res Microbiol"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0040","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/pmic.200800486","article-title":"Analysis of outer membrane porin complexes of Neisseria meningitidis in wild-type and specific knock-out mutant strains","volume":"9","author":"Marzoa","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0045","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1021\/pr9006409","article-title":"Identification of Neisseria meningitidis outer membrane vesicle complexes using 2-D high resolution clear native\/SDS-PAGE","volume":"9","author":"Marzoa","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0050","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1074\/mcp.M700076-MCP200","article-title":"High resolution clear native electrophoresis for in-gel functional assays and fluorescence studies of membrane protein complexes","volume":"6","author":"Wittig","year":"2007","journal-title":"Mol Cel Proteomics"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0055","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1128\/IAI.70.8.4028-4034.2002","article-title":"Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis","volume":"70","author":"Wright","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0060","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1128\/IAI.71.12.6844-6849.2003","article-title":"Conformational epitopes recognized by protective anti-neisserial surface protein A antibodies","volume":"71","author":"Hou","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0065","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0006-291X(03)01466-9","article-title":"Immunodominance of conformation-dependent B-cell epitopes of protein antigens","volume":"308","author":"Ito","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0070","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1128\/IAI.69.5.3082-3091.2001","article-title":"Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants","volume":"69","author":"Wolf","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0075","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1128\/IAI.68.10.5679-5689.2000","article-title":"Sequence polimorphism, predicted secondary structures, and surface-exposed conformational epitopes of Campylobacter major outer membrane protein","volume":"68","author":"Zang","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0080","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.171.4.1978","article-title":"The fourth surface-exposed region of the outer membrane protein P5-homologous adhesin of nontypable Haemophilus influenzae is an immunodominant but nonprotective decoying epitope","volume":"171","author":"Novotny","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0085","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2011.08.123_bib0090","doi-asserted-by":"crossref","first-page":"B112","DOI":"10.1016\/j.vaccine.2009.04.065","article-title":"Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease","volume":"27","author":"Frasch","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0095","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccine in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1586\/14760584.3.1.77","article-title":"Serologic correlates of protection for evaluating the response to meningococcal vaccines","volume":"3","author":"Balmer","year":"2004","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0928-8244(97)00109-0","article-title":"Bactericidal activity of antibodies elicited against the Neisseria meningitidis 37-kDa ferric binding protein (FbpA) with different adjuvants","volume":"20","author":"G\u00f3mez","year":"1998","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurent of protein using Bicinchonic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0115","first-page":"67","article-title":"Production, characterization and control of MenB-vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease","volume":"14","author":"Fredriksen","year":"1991","journal-title":"NIPH Ann"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0120","series-title":"The protein protocols handbook","first-page":"251","article-title":"Zinc-reverse staining technique","author":"Fen\u00e1ndez-Patr\u00f3n","year":"2002"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0125","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/IAI.50.2.510-516.1985","article-title":"Protection against infection with Neisseria meningitidis group B serotype 2b by passive immunization with serotype-specific monoclonal antibody","volume":"50","author":"Brodeur","year":"1985","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jsb.2004.03.011","article-title":"Conformational epitope mapping of OmpC, a major surface antigen from Salmonella typhi","volume":"148","author":"Arockiasamy","year":"2004","journal-title":"J Struct Biol"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0135","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/oxfordjournals.molbev.a003991","article-title":"Phylogenetic evidence for frequent positive selection and recombination in the meningococcal surface antigen PorB","volume":"19","author":"Urwin","year":"2002","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0140","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/CDLI.3.4.444-450.1996","article-title":"Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design","volume":"3","author":"Feavers","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0145","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/IAI.67.3.1267-1276.1999","article-title":"Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis","volume":"67","author":"Rosenqvist","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0150","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0882-4010(91)90041-8","article-title":"Blocking of bactericidal killing of Neisseria meningitidis by antibodies directed against class 4 outer membrane protein","volume":"11","author":"Munkley","year":"1991","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0155","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1002\/pmic.200500821","article-title":"Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98\/254","volume":"6","author":"Vipond","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0160","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1016\/S0264-410X(01)00008-1","article-title":"Immunogenicity of recombinant class 1 protein from Neisseria meningitidis refolded in phospholipid vesicles and detergent","volume":"19","author":"Niebla","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0165","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.vaccine.2005.10.003","article-title":"Heterologous prime-boost strategy to overcome weak immunogenicity of two serosubtypes in hexavalent Neisseria meningitidis outer membrane vesicle vaccine","volume":"24","author":"Luijkx","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0170","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1016\/j.vaccine.2010.04.082","article-title":"Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process","volume":"28","author":"Van de Waterbeemd","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0175","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1016\/j.vaccine.2009.06.086","article-title":"Characterisation and immune responses to meningococcal recombinant porin complexes incorporated into liposomes","volume":"27","author":"S\u00e1nchez","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0180","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1128\/IAI.70.7.3752-3758.2002","article-title":"Complement activation and formation of the membrane attack complex on serogroup B Neisseria meningitidis in the presence or absence of serum bactericidal activity","volume":"70","author":"Drogari-Apiranthitou","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0185","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/pmic.200500164","article-title":"Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles","volume":"6","author":"Ferrari","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0190","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/IAI.00701-09","article-title":"Immunoproteomic analysis of the development of natural immunity in subjects colonized by Neisseria meningitidis reveals potential vaccine candidates","volume":"77","author":"Williams","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0195","doi-asserted-by":"crossref","first-page":"e5940","DOI":"10.1371\/journal.pone.0005940","article-title":"Towards the immunoproteome of Neisseria meningitidis","volume":"4","author":"Mendum","year":"2009","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2011.08.123_bib0200","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.vaccine.2009.04.066","article-title":"Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease","volume":"27 Suppl","author":"Granoff","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0205","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1128\/IAI.05019-11","article-title":"The Neisseria meningitidis macrophage infectivity potentiator (MIP) protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate","volume":"79","author":"Hung","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.123_bib0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.0300-9475.2004.01362.x","article-title":"The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis","volume":"59","author":"Michaelsen","year":"2004","journal-title":"Scand J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11014009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11014009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T16:23:14Z","timestamp":1592929394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11014009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":42,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0264410X11014009"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.08.123","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}